Altered colorectal afferent function associated with TNBS-induced visceral hypersensitivity in mice.

Inflammation of the distal bowel is often associated with abdominal pain and hypersensitivity, but whether and which colorectal afferents contribute to the hypersensitivity is unknown. Using a mouse model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis, we investigated colorectal hypersensitivity following intracolonic TNBS and associated changes in colorectum and afferent functions. C57BL/6 mice were treated intracolonically with TNBS or saline.

Long-term sensitization of mechanosensitive and -insensitive afferents in mice with persistent colorectal hypersensitivity.

Afferent input contributes significantly to the pain and colorectal hypersensitivity that characterize irritable bowel syndrome. In the present study, we investigated the contributions of mechanically sensitive and mechanically insensitive afferents (MIAs; or silent afferents) to colorectal hypersensitivity. The visceromotor response to colorectal distension (CRD; 15-60 mmHg) was recorded in mice before and for weeks after intracolonic treatment with zymosan or saline.

Photocatalytic inactivation of E. coli in surface water using immobilised nanoparticle TiO2 films.

Photocatalysis is a promising method for the disinfection of potable water in developing countries where solar irradiation can be employed, thus reducing the cost of treatment. In addition to microbial contamination, water normally contains suspended solids, dissolved inorganic ions and organic compounds (mainly humic substances) which may affect the efficacy of solar photocatalysis. In this work the photocatalytic and photolytic inactivation rates of Escherichia coli using immobilised nanoparticle TiO2 films were found to be significantly lower in surface water samples in comparison to distilled water.

Lack of toxicity of a STAT3 decoy oligonucleotide.

Background: STAT3 overexpression has been detected in several cancers including head and neck squamous cell carcinoma (HNSCC). Previous studies using intratumoral administration of a STAT3 decoy oligonucleotide that abrogates STAT3-mediated gene transcription in preclinical cancer models have demonstrated antitumor efficacy. This study was conducted to observe the toxicity and biologic effects of the STAT3 decoy in a non-human primate model, in anticipation of initiating a clinical trial in HNSCC patients.